334 related articles for article (PubMed ID: 18824582)
1. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.
Bull MJ; Williams AS; Mecklenburgh Z; Calder CJ; Twohig JP; Elford C; Evans BA; Rowley TF; Slebioda TJ; Taraban VY; Al-Shamkhani A; Wang EC
J Exp Med; 2008 Oct; 205(11):2457-64. PubMed ID: 18824582
[TBL] [Abstract][Full Text] [Related]
2. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss.
Collins FL; Williams JO; Bloom AC; Singh RK; Jordan L; Stone MD; McCabe LR; Wang ECY; Williams AS
Bone; 2017 Apr; 97():94-104. PubMed ID: 28062298
[TBL] [Abstract][Full Text] [Related]
3. Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3.
Wang EC; Newton Z; Hayward OA; Clark SR; Collins F; Perks WV; Singh RK; Twohig JP; Williams AS
Arthritis Rheumatol; 2014 Oct; 66(10):2762-72. PubMed ID: 25044706
[TBL] [Abstract][Full Text] [Related]
4. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses.
Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H
J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642
[TBL] [Abstract][Full Text] [Related]
5. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
6. A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell.
Hashiramoto A; Konishi Y; Murayama K; Kawasaki H; Yoshida K; Tsumiyama K; Tanaka K; Mizuhara M; Shiotsuki T; Kitamura H; Komai K; Kimura T; Yagita H; Shiozawa K; Shiozawa S
J Biol Chem; 2018 Feb; 293(6):1933-1943. PubMed ID: 29180447
[TBL] [Abstract][Full Text] [Related]
7. Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF.
Song YJ; Choi IA; Meylan F; Demoruelle MK; Farley T; Richard AC; Hawley E; Botson J; Hong YJ; Lee EY; Mian SR; Hamilton BC; Thiele GM; Mikuls TR; Gara N; Ward CD; Lamberth S; Deane KD; Heller T; Ward MM; Lee DM; Migone TS; Stohl W; O'Dell JR; Norris JM; Holers VM; Gregersen P; Song YW; Siegel RM
Arthritis Res Ther; 2020 May; 22(1):106. PubMed ID: 32381123
[TBL] [Abstract][Full Text] [Related]
8. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
9. Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.
Liu C; Li XX; Gao W; Liu W; Liu DS
PLoS One; 2014; 9(3):e92743. PubMed ID: 24651300
[TBL] [Abstract][Full Text] [Related]
10. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
12. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice.
Collins FL; Williams JO; Bloom AC; Stone MD; Choy E; Wang EC; Williams AS
J Immunol Res; 2015; 2015():901679. PubMed ID: 26065008
[TBL] [Abstract][Full Text] [Related]
13. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
[TBL] [Abstract][Full Text] [Related]
14. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
[TBL] [Abstract][Full Text] [Related]
15. TL1A increased IL-6 production on fibroblast-like synoviocytes by preferentially activating TNF receptor 2 in rheumatoid arthritis.
Ma Z; Wang B; Wang M; Sun X; Tang Y; Li M; Li F; Li X
Cytokine; 2016 Jul; 83():92-98. PubMed ID: 27081759
[TBL] [Abstract][Full Text] [Related]
16. TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis.
Zhou M; Liu R; Su D; Feng X; Li X
Cytokine; 2014 Sep; 69(1):125-30. PubMed ID: 24832108
[TBL] [Abstract][Full Text] [Related]
17. Immunology: TL1A in the inflammatory network in autoimmune diseases.
Bayry J
Nat Rev Rheumatol; 2010 Feb; 6(2):67-8. PubMed ID: 20125169
[TBL] [Abstract][Full Text] [Related]
18. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.
Perks WV; Singh RK; Jones GW; Twohig JP; Williams AS; Humphreys IR; Taylor PR; Jones SA; Wang ECY
Am J Pathol; 2016 Nov; 186(11):2813-2823. PubMed ID: 27664471
[TBL] [Abstract][Full Text] [Related]
19. Soluble TL1A is sufficient for activation of death receptor 3.
Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
